4
Changes in Ownership
Mirum Pharmaceuticals, Inc. Filed Acc 0001197350-26-000007
CHIEF FINANCIAL OFFICER sold 5,000 shares at an average $93.82 ($469,077)
- CHIEF FINANCIAL OFFICER acquired 2,393 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BJERKHOLT ERIC · CHIEF FINANCIAL OFFICER
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-08 | Sale : show line 1 in the form 10b5-1 | −2,258 | $92.84 | $209,633 | 47,530 | D |
| 2026-06-08 | Sale : show line 2 in the form 10b5-1 | −1,175 | $93.95 | $110,391 | 46,355 | D |
| 2026-06-08 | Sale : show line 3 in the form 10b5-1 | −1,567 | $95.12 | $149,053 | 44,788 | D |
| 2026-06-09 | Exercise or conversion : show line 4 in the form 10b5-1 | +2,393 | $26.49 | $63,391 | 47,181 | D |
| Open-market sales · 5,000 sh · avg $93.82 · $469,077 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-09 | Exercise or conversion : show line 5 in the form 10b5-1 Employee Stock Option (right to buy) | −2,393 | 26,653 | D |
Loading xslF345X06/form4-06102026_010600.xml…